← Leaderboards
Michael J Morris
Sloan-Kettering Institute For Cancer Res
$6,941,101
Attributed
$15,563,373
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,913,109 · 9
By mechanism
P50$9,863,471 · 5
UG1$5,417,140 · 1
R01$4,262,087 · 1
U10$2,696,896 · 1
K23$673,515 · 1
Top collaborators
- Carol Aghajanian9 shared
- Oliver Zivanovic9 shared
- Martin S Tallman8 shared
- Lawrence H Schwartz6 shared
- Katherine S Panageas5 shared
- Simon N Powell5 shared
- Deborah Schrag5 shared
- Nancy Y Lee4 shared
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- David A Scheinberg$21,198,583
- Lawrence H Schwartz$9,739,750
- Richard J O'Reilly$17,498,839
Others in their field
Top investigators on “Oncology”
- Larry Arthur$365,424,300
- David Heimbrook · Leidos Biomedical Research, Inc.$284,312,591
- Gregory H Reaman · National Childhood Cancer Foundation$243,308,665
- Norman Wolmark · Nsabp Foundation, Inc.$233,216,600
- Charles A Coltman · Southwest Oncology Group$199,580,977
- Peter C Adamson · National Childhood Cancer Foundation$192,690,226
Research focus
OncologyResourcesResearch PersonnelMalignant NeoplasmsClinical TrialsCaringSiteTrainingImageMissionData ScienceRandomizedCancer CareHomeMultidisciplinaryMentorsMemberCare DeliveryEvidence BaseTelehealthData StreamsMalignant Neoplasm Of ProstateLeadershipCommunication
Grant awards (34)
SPORE in Prostate Cancer$2,126,579
P50 · FY2025 · CA
MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe$1,238,986
P50 · FY2025 · CA
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$765,415
R01 · FY2025 · CA
Pragmatic Trial$316,888
P50 · FY2025 · CA · contact PI
MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe$1,177,039
P50 · FY2024 · CA
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$914,388
R01 · FY2024 · CA
Administrative Core$426,173
P50 · FY2024 · CA · contact PI
Pragmatic Trial$318,889
P50 · FY2024 · CA · contact PI
MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe$1,214,206
P50 · FY2023 · CA
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$974,889
R01 · FY2023 · CA
Administrative Core$353,942
P50 · FY2023 · CA · contact PI
MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe - Addressing missing data in the MATCHES study to improve ML/AI readiness$353,942
P50 · FY2023 · CA
Pragmatic Trial$319,087
P50 · FY2023 · CA · contact PI
Administrative Core$264,300
P50 · FY2023 · CA · contact PI
Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center$1,273,035
UG1 · FY2022 · CA
MATCHES: Making Telehealth Delivery of Cancer Care at Home Effective and Safe$1,238,984
P50 · FY2022 · CA
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$689,898
R01 · FY2022 · CA
Administrative Core$291,376
P50 · FY2022 · CA · contact PI
Pragmatic Trial$223,080
P50 · FY2022 · CA · contact PI
Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center$1,598,035
UG1 · FY2021 · CA
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$197,785
R01 · FY2021 · CA
Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center$1,273,035
UG1 · FY2020 · CA
Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer$719,712
R01 · FY2020 · CA
Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer Center$1,273,035
UG1 · FY2019 · CA
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$922,200
U10 · FY2018 · CA
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$145,357
U10 · FY2018 · CA
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$737,200
U10 · FY2017 · CA
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$154,939
U10 · FY2017 · CA
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center$737,200
U10 · FY2016 · CA
Radioimmunotherapy for Prostate Cancer$134,703
K23 · FY2007 · CA · contact PI
Radioimmunotherapy for Prostate Cancer$134,703
K23 · FY2006 · CA · contact PI
Radioimmunotherapy for Prostate Cancer$134,703
K23 · FY2005 · CA
Radioimmunotherapy for Prostate Cancer$134,703
K23 · FY2004 · CA
Radioimmunotherapy for Prostate Cancer$134,703
K23 · FY2003 · CA